ConductScience.org, home

Paper39335124

Therapeutic Opportunities for Biomarkers in Metastatic Spine Tumors.

Schroeder C and 9 others. Cancers (Basel), 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Therapeutic Opportunities for Biomarkers in Metastatic Spine Tumors. Papers, record 39335124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39335124

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic Opportunities for Biomarkers in Metastatic Spine Tumors.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.67, provisional
iCite
Revised in PubMed
2024-09-30
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schroeder CChristian
2Campilan BBeatricehttps://orcid.org/0000-0003-1687-3474
3Leary OPOwen P
4Arditi JJonathan
5Michles MJMadison J
6De La Garza Ramos RRafaelhttps://orcid.org/0000-0002-5536-2514
7Akinduro OOOluwaseun O
8Gokaslan ZLZiya L
9Martinez Moreno MMargothttps://orcid.org/0000-0003-1137-1651
10Sullivan PLZPatricia L Zadnik

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References117

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127551478FGFR1 inhibition in lung squamous cell carcinoma: questions and controversies.Cell Death Discov2015https://conductscience.org/library/papers/27551478PubMed
231900168Tumor microenvironment differences between primary tumor and brain metastases.J Transl Med2020https://conductscience.org/library/papers/31900168PubMed
326977847The evolving role of immunotherapy in prostate cancer.Curr Opin Oncol2016https://conductscience.org/library/papers/26977847PubMed
426122181ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer.Nat Rev Clin Oncol2015https://conductscience.org/library/papers/26122181PubMed
531137764Prostate Cancer and Bone Metastases: The Underlying Mechanisms.Int J Mol Sci2019https://conductscience.org/library/papers/31137764PubMed
624239464Biomarkers of renal cell carcinoma.Urol Oncol2014https://conductscience.org/library/papers/24239464PubMed
725504108Downregulation of CXCR4 by SDF-KDEL in SBC-5 cells inhibits their migration in vitro and organ metastasis in vivo.Int J Mol Med2015https://conductscience.org/library/papers/25504108PubMed
82997622L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.Nature1985https://conductscience.org/library/papers/2997622PubMed
923401436ALK in lung cancer: past, present, and future.J Clin Oncol2013https://conductscience.org/library/papers/23401436PubMed
1023912959CX3CL1 expression is associated with poor outcome in breast cancer patients.Breast Cancer Res Treat2013https://conductscience.org/library/papers/23912959PubMed
1135783639A Novel Overall Survival Prediction Signature Based on Comprehensive Research in Prostate Cancer Bone Metastases.Front Med (Lausanne)2022https://conductscience.org/library/papers/35783639PubMed
1221678053Down-regulation of β3-integrin inhibits bone metastasis of small cell lung cancer.Mol Biol Rep2012https://conductscience.org/library/papers/21678053PubMed
1324482365PTEN is a potent suppressor of small cell lung cancer.Mol Cancer Res2014https://conductscience.org/library/papers/24482365PubMed
1430345906Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.N Engl J Med2018https://conductscience.org/library/papers/30345906PubMed
1537690663Metabolic signature biomarkers for predicting the recurrence of urological cancers.Clin Chim Acta2023https://conductscience.org/library/papers/37690663PubMed
1622695242The role of genetic markers in the management of prostate cancer.Eur Urol2012https://conductscience.org/library/papers/22695242PubMed
1731091374Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.N Engl J Med2019https://conductscience.org/library/papers/31091374PubMed
1834098744KEYNOTE-921: Phase III study of pembrolizumab plus docetaxel for metastatic castration-resistant prostate cancer.Future Oncol2021https://conductscience.org/library/papers/34098744PubMed
1925220842Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.Int J Cancer2015https://conductscience.org/library/papers/25220842PubMed
2032657049Genetic profile of non-small cell lung cancer (NSCLC): A hospital-based survey in Jinhua.Mol Genet Genomic Med2020https://conductscience.org/library/papers/32657049PubMed

See all 117 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41744820CHI3L1 Expression in Chordoma: Implications for Immunotherapeutic Intervention.Cells2026https://conductscience.org/library/papers/41744820PubMed
40868304Artificial Intelligence for Non-Invasive Prediction of Molecular Signatures in Spinal Metastases: A Systematic Review.Bioengineering (Basel)2025https://conductscience.org/library/papers/40868304PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39335124

GET https://conductscience.org/api/papers/v1/39335124/references?page=2